Phillippa Taberlay

Prof. Phillippa Taberlay

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2016 in Genome Research
Verified
Journal Article
Open access
PDF file
PTPhillippa Taberlay
Phillippa Taberlay
JAJoanna Achinger-Kawecka
Joanna Achinger-Kawecka
ALAaron T.L. Lun
Aaron T.L. Lun
FBFabian A. Buske
Fabian A. Buske
KSKenneth Sabir
Kenneth Sabir
SCSusan J. Clark
Susan J. Clark
A three-dimensional chromatin state underpins the structural and functional basis of the genome by bringing regulatory elements and genes into close spatial proximity to ensure proper, cell-type–specific gene expression profiles. Here, we performed Hi-C chromosome conformation capture sequencing to investigate how three-dimensional chromatin organization is disrupted in the context of copy-number variation, long-range epigenetic remodeling, and atypical gene expression programs in prostate cancer. We find that cancer cells retain the ability to segment their genomes into megabase-sized topologically associated domains (TADs); however, these domains are generally smaller due to establishment of additional domain boundaries. Interestingly, a large proportion of the new cancer-specific domain boundaries occur at regions that display copy-number variation. Notably, a common deletion on 17p13.1 in prostate cancer spanning the TP53 tumor suppressor locus results in bifurcation of a single TAD into two distinct smaller TADs. Change in domain structure is also accompanied by novel cancer-specific chromatin interactions within the TADs that are enriched at regulatory elements such as enhancers, promoters, and insulators, and associated with alterations in gene expression. We also show that differential chromatin interactions across regulatory regions occur within long-range epigenetically activated or silenced regions of concordant gene activation or repression in prostate cancer. Finally, we present a novel visualization tool that enables integrated exploration of Hi-C interaction data, the transcriptome, and epigenome. This study provides new insights into the relationship between long-range epigenetic and genomic dysregulation and changes in higher-order chromatin interactions in cancer.

17 December 2019 in Essays in Biochemistry
Verified
Journal Article
Open access
PDF file
KSKsenia Skvortsova
Ksenia Skvortsova
CSClare Stirzaker
Clare Stirzaker
PTPhillippa Taberlay
Phillippa Taberlay
As one of the most abundant and well-studied epigenetic modifications, DNA methylation plays an essential role in normal development and cellular biology. Global alterations to the DNA methylation landscape contribute to alterations in the transcriptome and deregulation of cellular pathways. Indeed, improved methods to study DNA methylation patterning and dynamics at base pair resolution and across individual DNA molecules on a genome-wide scale has highlighted the scope of change to the DNA methylation landscape in disease states, particularly during tumorigenesis. More recently has been the development of DNA hydroxymethylation profiling techniques, which allows differentiation between 5mC and 5hmC profiles and provides further insights into DNA methylation dynamics and remodeling in tumorigenesis. In this review, we describe the distribution of DNA methylation and DNA hydroxymethylation in different genomic contexts, first in normal cells, and how this is altered in cancer. Finally, we discuss DNA methylation profiling technologies and the most recent advances in single-cell methods, bisulfite-free approaches and ultra-long read sequencing techniques.

1 May 2012 in Cancer Cell
Verified
Journal Article
Closed access
DCDaniel D. De Carvalho
Daniel D. De Carvalho
SSShikhar Sharma
Shikhar Sharma
JYJueng Soo You
Jueng Soo You
SSSheng-Fang Su
Sheng-Fang Su
PTPhillippa Taberlay
Phillippa Taberlay
PJPeter A. Jones
Peter A. Jones

10 June 2014 in Genome Research
Verified
Journal Article
Open access
PDF file
PTPhillippa Taberlay
Phillippa Taberlay
ASAaron L. Statham
Aaron L. Statham
TKTheresa K. Kelly
Theresa K. Kelly
SCSusan J. Clark
Susan J. Clark
PJPeter A. Jones
Peter A. Jones
It is well established that cancer-associated epigenetic repression occurs concomitant with CpG island hypermethylation and loss of nucleosomes at promoters, but the role of nucleosome occupancy and epigenetic reprogramming at distal regulatory elements in cancer is still poorly understood. Here, we evaluate the scope of global epigenetic alterations at enhancers and insulator elements in prostate and breast cancer cells using simultaneous genome-wide mapping of DNA methylation and nucleosome occupancy (NOMe-seq). We find that the genomic location of nucleosome-depleted regions (NDRs) is mostly cell type specific and preferentially found at enhancers in normal cells. In cancer cells, however, we observe a global reconfiguration of NDRs at distal regulatory elements coupled with a substantial reorganization of the cancer methylome. Aberrant acquisition of nucleosomes at enhancer-associated NDRs is associated with hypermethylation and epigenetic silencing marks, and conversely, loss of nucleosomes with demethylation and epigenetic activation. Remarkably, we show that nucleosomes remain strongly organized and phased at many facultative distal regulatory elements, even in the absence of a NDR as an anchor. Finally, we find that key transcription factor (TF) binding sites also show extensive peripheral nucleosome phasing, suggesting the potential for TFs to organize NDRs genome-wide and contribute to deregulation of cancer epigenomes. Together, our findings suggest that “decommissioning” of NDRs and TFs at distal regulatory elements in cancer cells is accompanied by DNA hypermethylation susceptibility of enhancers and insulator elements, which in turn may contribute to an altered genome-wide architecture and epigenetic deregulation in malignancy.

1 February 2014 in Trends in Genetics
Verified
Journal Article
Closed access
CSClare Stirzaker
Clare Stirzaker
PTPhillippa Taberlay
Phillippa Taberlay
ASAaron L. Statham
Aaron L. Statham
SCSusan J. Clark
Susan J. Clark

1 May 2021 in Molecular Cell
Verified
Journal Article
Closed access
SHSimon J Hogg
Simon J Hogg
OMOlga Motorna
Olga Motorna
LCLeonie A Cluse
Leonie A Cluse
TJTimothy M Johanson
Timothy M Johanson
HCHannah D Coughlan
Hannah D Coughlan
RJRicky W Johnstone
Ricky W Johnstone